{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:47:12Z","timestamp":1761518832788},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T00:00:00Z","timestamp":1160006400000},"content-version":"vor","delay-in-days":7857,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[1985,4]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> The anthelminthic natural product avermectin B<jats:sub>la<\/jats:sub> (AVM) modulates the binding of \u03b3\u2010aminobutyric acid (GABA) and benzodiazepine (BZ) receptor ligands to membrane homogenates of mammalian brain. The potent (EC<jats:sub>50<\/jats:sub>= 40 n<jats:italic>M<\/jats:italic>) enhancement by AVM of [<jats:sup>3<\/jats:sup>H]diazepam binding to rat or bovine brain membranes resembled that of barbiturates and pyrazolopyridines in being inhibited (partially) by the convulsants picrotoxin, bicuculline, and strychnine, and by the anticonvulsants phenobarbital and chlormethiazole. The maximal effect of AVM was not increased by pentobarbital or etazolate. However, AVM affected BZ receptor subpopulations or conformational states in a manner different from pentobarbital. Further, unlike pentobarbital and etazolate, AVM did not inhibit allosterically the binding of the BZ receptor inverse agonist [<jats:sup>3<\/jats:sup>H]\u03b2\u2010carboline\u20103\u2010carboxylate methyl ester, nor did it inhibit, but rather enhanced, the binding of the cage convulsant [<jats:sup>35<\/jats:sup>S]<jats:italic>t<\/jats:italic>\u2010butyl bicyclophosphorothionate to picrotoxin receptor sites. AVM at submicromolar concentrations had the opposite effect of pentobarbital and etazolate on GABA receptor binding, decreasing by half the high\u2010affinity binding of [<jats:sup>3<\/jats:sup>H]GABA and related agonist ligands, and increasing by over twofold the binding of the antagonist [<jats:sup>3<\/jats:sup>H]bicuculline methochloride, an effect that was potentiated by picrotoxin. AVM also reversed the enhancement of GABA agonists and inhibition of GABA antagonist binding by barbiturates and pyrazolopyridines. These overall effects of AVM are unique and require the presence of another separate drug receptor site on the GABA\/BZ receptor complex.<\/jats:p>","DOI":"10.1111\/j.1471-4159.1985.tb08727.x","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T16:16:50Z","timestamp":1160065010000},"page":"1074-1082","source":"Crossref","is-referenced-by-count":56,"title":["Avermectin B<sub>la<\/sub> Modulation of \u03b3\u2010Aminobutyric Acid\/Benzodiazepine Receptor Binding in Mammalian Brain"],"prefix":"10.1111","volume":"44","author":[{"given":"Richard W.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele M.","family":"Snowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,10,5]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(81)90333-4"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(78)90385-2"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/294472a0"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90133-X"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90157-2"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.4.2062"},{"key":"e_1_2_2_8_1","first-page":"113","volume-title":"Anxiolytics: Neurochemical, Behavioral, and Clinical Perspectives","author":"Haefely W.","year":"1983"},{"key":"e_1_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.10.6211"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(84)80280-6"},{"key":"e_1_2_2_11_1","first-page":"320","article-title":"Interactions of barbiturates of various pharmacological categories with benzodiazepine receptors","volume":"21","author":"Leeb\u2010Lundberg F.","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_12_1","first-page":"315","article-title":"Heterogeneity of benzodiazepine receptor interactions with GABA and barbiturate receptor sites","volume":"23","author":"Leeb\u2010Lundberg L. M. F.","year":"1983","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7468"},{"key":"e_1_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.01-05-00471.1981"},{"key":"e_1_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(81)90309-5"},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1981.tb05284.x"},{"key":"e_1_2_2_18_1","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1523\/JNEUROSCI.02-12-01812.1982","article-title":"Chloride\u2010dependent enhancement by barbiturates of GABA receptor binding","volume":"2","author":"Olsen R. W.","year":"1982","journal-title":"J. Neurosci."},{"key":"e_1_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1983.tb00877.x"},{"key":"e_1_2_2_20_1","first-page":"217","article-title":"\u03b3\u2010Aminobutyric acid receptor binding in mammalian brain: heterogeneity of binding sites","volume":"19","author":"Olsen R. W.","year":"1981","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.105.8.168-a"},{"key":"e_1_2_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(80)91402-3"},{"key":"e_1_2_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(80)90155-0"},{"key":"e_1_2_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1982.tb08639.x"},{"key":"e_1_2_2_25_1","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1523\/JNEUROSCI.02-07-00966.1982","article-title":"A comparative study of avermectin Bla and other modulators of the \u03b3\u2010aminobutyric acid receptor\u2010chloride ion channel complex","volume":"2","author":"Pong S. S.","year":"1982","journal-title":"J. Neurosci."},{"key":"e_1_2_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(82)90365-2"},{"key":"e_1_2_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(82)90936-2"},{"key":"e_1_2_2_28_1","first-page":"326","article-title":"[35]t\u2010Butylbicyclophosphorothionate binds with high affinity to brain\u2010specific sites coupled to \u03b3\u2010aminobutyric acid\u2010A and ion recognition sites","volume":"23","author":"Squires R. F.","year":"1983","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_2_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1981.tb01664.x"},{"key":"e_1_2_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(81)90213-2"},{"key":"e_1_2_2_31_1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1523\/JNEUROSCI.04-05-01193.1984","article-title":"[35S]t\u2010Butylbicyclophosphorothionate binding sites are constituents of the GABA benzodiazepine receptor complex","volume":"4","author":"Supavilai P.","year":"1984","journal-title":"J. Neurosci."},{"key":"e_1_2_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90630-6"},{"key":"e_1_2_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(84)91311-1"},{"key":"e_1_2_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(82)90260-X"},{"key":"e_1_2_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90367-9"},{"key":"e_1_2_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(82)90133-9"},{"key":"e_1_2_2_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1984.tb02746.x"},{"key":"e_1_2_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90183-3"},{"key":"e_1_2_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7742(08)60219-6"},{"key":"e_1_2_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90252-8"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.1985.tb08727.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.1985.tb08727.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T17:24:09Z","timestamp":1697822649000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.1985.tb08727.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985,4]]}},"alternative-id":["10.1111\/j.1471-4159.1985.tb08727.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.1985.tb08727.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,4]]}}}